JP2011525536A5 - - Google Patents

Download PDF

Info

Publication number
JP2011525536A5
JP2011525536A5 JP2011516543A JP2011516543A JP2011525536A5 JP 2011525536 A5 JP2011525536 A5 JP 2011525536A5 JP 2011516543 A JP2011516543 A JP 2011516543A JP 2011516543 A JP2011516543 A JP 2011516543A JP 2011525536 A5 JP2011525536 A5 JP 2011525536A5
Authority
JP
Japan
Prior art keywords
active agent
less
mucoadhesive
max
minutes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2011516543A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011525536A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2009/048325 external-priority patent/WO2010008863A1/en
Publication of JP2011525536A publication Critical patent/JP2011525536A/ja
Publication of JP2011525536A5 publication Critical patent/JP2011525536A5/ja
Pending legal-status Critical Current

Links

JP2011516543A 2008-06-23 2009-06-23 多方向性粘膜送達装置および使用法 Pending JP2011525536A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US7491808P 2008-06-23 2008-06-23
US61/074,918 2008-06-23
PCT/US2009/048325 WO2010008863A1 (en) 2008-06-23 2009-06-23 Multidirectional mucosal delivery devices and methods of use

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2014230432A Division JP2015052003A (ja) 2008-06-23 2014-11-13 多方向性粘膜送達装置および使用法

Publications (2)

Publication Number Publication Date
JP2011525536A JP2011525536A (ja) 2011-09-22
JP2011525536A5 true JP2011525536A5 (enExample) 2013-05-23

Family

ID=41550666

Family Applications (5)

Application Number Title Priority Date Filing Date
JP2011516543A Pending JP2011525536A (ja) 2008-06-23 2009-06-23 多方向性粘膜送達装置および使用法
JP2014230432A Pending JP2015052003A (ja) 2008-06-23 2014-11-13 多方向性粘膜送達装置および使用法
JP2016215881A Pending JP2017019878A (ja) 2008-06-23 2016-11-04 多方向性粘膜送達装置および使用法
JP2019123542A Pending JP2019156859A (ja) 2008-06-23 2019-07-02 多方向性粘膜送達装置および使用法
JP2021090747A Pending JP2021121639A (ja) 2008-06-23 2021-05-31 多方向性粘膜送達装置および使用法

Family Applications After (4)

Application Number Title Priority Date Filing Date
JP2014230432A Pending JP2015052003A (ja) 2008-06-23 2014-11-13 多方向性粘膜送達装置および使用法
JP2016215881A Pending JP2017019878A (ja) 2008-06-23 2016-11-04 多方向性粘膜送達装置および使用法
JP2019123542A Pending JP2019156859A (ja) 2008-06-23 2019-07-02 多方向性粘膜送達装置および使用法
JP2021090747A Pending JP2021121639A (ja) 2008-06-23 2021-05-31 多方向性粘膜送達装置および使用法

Country Status (9)

Country Link
US (7) US20110189259A1 (enExample)
EP (1) EP2293751B1 (enExample)
JP (5) JP2011525536A (enExample)
CN (2) CN105833420A (enExample)
AU (1) AU2009271271A1 (enExample)
BR (1) BRPI0915386B8 (enExample)
CA (1) CA2728912C (enExample)
ES (1) ES2663777T3 (enExample)
WO (1) WO2010008863A1 (enExample)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5968547A (en) 1997-02-24 1999-10-19 Euro-Celtique, S.A. Method of providing sustained analgesia with buprenorphine
US20070281003A1 (en) 2001-10-12 2007-12-06 Fuisz Richard C Polymer-Based Films and Drug Delivery Systems Made Therefrom
US20110033542A1 (en) 2009-08-07 2011-02-10 Monosol Rx, Llc Sublingual and buccal film compositions
US8765167B2 (en) 2001-10-12 2014-07-01 Monosol Rx, Llc Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
US7357891B2 (en) 2001-10-12 2008-04-15 Monosol Rx, Llc Process for making an ingestible film
US8900497B2 (en) 2001-10-12 2014-12-02 Monosol Rx, Llc Process for making a film having a substantially uniform distribution of components
US8900498B2 (en) 2001-10-12 2014-12-02 Monosol Rx, Llc Process for manufacturing a resulting multi-layer pharmaceutical film
US11207805B2 (en) 2001-10-12 2021-12-28 Aquestive Therapeutics, Inc. Process for manufacturing a resulting pharmaceutical film
US20190328679A1 (en) 2001-10-12 2019-10-31 Aquestive Therapeutics, Inc. Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
US10285910B2 (en) 2001-10-12 2019-05-14 Aquestive Therapeutics, Inc. Sublingual and buccal film compositions
US8603514B2 (en) 2002-04-11 2013-12-10 Monosol Rx, Llc Uniform films for rapid dissolve dosage form incorporating taste-masking compositions
AU2007275581B2 (en) 2006-07-21 2011-09-08 Biodelivery Sciences International, Inc. Transmucosal delivery devices with enhanced uptake
US8475832B2 (en) 2009-08-07 2013-07-02 Rb Pharmaceuticals Limited Sublingual and buccal film compositions
US9149959B2 (en) 2010-10-22 2015-10-06 Monosol Rx, Llc Manufacturing of small film strips
US8939943B2 (en) 2011-01-26 2015-01-27 Kaleo, Inc. Medicament delivery device for administration of opioid antagonists including formulations for naloxone
US8627816B2 (en) 2011-02-28 2014-01-14 Intelliject, Inc. Medicament delivery device for administration of opioid antagonists including formulations for naloxone
US8601691B2 (en) 2011-04-27 2013-12-10 General Electric Company Component and methods of fabricating a coated component using multiple types of fillers
WO2013026064A1 (en) 2011-08-18 2013-02-21 Biodelivery Sciences International, Inc. Abuse-resistant mucoadhesive devices for delivery of buprenorphine
US20130086784A1 (en) 2011-10-06 2013-04-11 General Electric Company Repair methods for cooled components
KR20190110628A (ko) * 2011-12-21 2019-09-30 바이오딜리버리 사이언시스 인터내셔널 인코포레이티드 만성 통증 완화에 이용되는 점막 관통 약물 전달 장치
US9901539B2 (en) 2011-12-21 2018-02-27 Biodelivery Sciences International, Inc. Transmucosal drug delivery devices for use in chronic pain relief
US9435208B2 (en) 2012-04-17 2016-09-06 General Electric Company Components with microchannel cooling
WO2013171146A1 (en) * 2012-05-15 2013-11-21 Lts Lohmann Therapie-Systeme Ag Oral film containing enteric release opiate resinate
KR20140030526A (ko) * 2012-08-31 2014-03-12 동국대학교 산학협력단 유동적 위장관점막 부착성 경구투여용 제형
US11931227B2 (en) 2013-03-15 2024-03-19 Cook Medical Technologies Llc Bimodal treatment methods and compositions for gastrointestinal lesions with active bleeding
US9867818B2 (en) 2013-09-10 2018-01-16 Insys Development Company, Inc. Sublingual buprenorphine spray
US9839611B2 (en) 2013-09-10 2017-12-12 Insys Development Company, Inc. Sublingual buprenorphine spray
US9918981B2 (en) 2013-09-10 2018-03-20 Insys Development Company, Inc. Liquid buprenorphine formulations
EP3043777B1 (en) 2013-09-10 2020-04-22 Fresh Cut Development, LLC Sublingual buprenorphine spray
US10722510B2 (en) 2014-07-08 2020-07-28 Hikma Pharmaceuticals Usa Inc. Liquid naloxone spray
WO2016007245A1 (en) 2014-07-08 2016-01-14 Insys Pharma, Inc. Sublingual naloxone spray
US10617686B2 (en) 2014-07-08 2020-04-14 Hikma Pharmaceuticals Usa Inc. Liquid naloxone spray
US9517307B2 (en) 2014-07-18 2016-12-13 Kaleo, Inc. Devices and methods for delivering opioid antagonists including formulations for naloxone
US9956323B2 (en) 2014-12-18 2018-05-01 Cook Medical Technologies Llc Medical devices for local bioactive delivery
US12427121B2 (en) 2016-05-05 2025-09-30 Aquestive Therapeutics, Inc. Enhanced delivery epinephrine compositions
US11273131B2 (en) 2016-05-05 2022-03-15 Aquestive Therapeutics, Inc. Pharmaceutical compositions with enhanced permeation
US12433850B2 (en) 2016-05-05 2025-10-07 Aquestive Therapeutics, Inc. Enhanced delivery epinephrine and prodrug compositions
JP7653218B2 (ja) 2016-05-05 2025-03-28 アクエスティブ セラピューティクス インコーポレイテッド 送達増強エピネフリン組成物
JPWO2019059377A1 (ja) 2017-09-22 2020-11-12 株式会社 メドレックス 再貼付不可能な貼付剤
WO2019067680A1 (en) 2017-09-27 2019-04-04 Cook Medical Technologies Llc CROSSLINKING SUBMUCOSAL INJECTION SYSTEM
GB2574878A (en) * 2018-06-22 2019-12-25 Biofilm Ltd Oral compositions and mucoadhesive thin films formed therefrom
CN109276333B (zh) * 2018-10-25 2021-02-26 杭州口腔医院集团有限公司 用于口腔种植修复附着龈增宽的装置及方法
CN115151336B (zh) * 2019-10-02 2025-02-11 海德奥克赛斯控股有限公司 耐用膜及其制备和用途
EP3936112A1 (en) * 2020-07-07 2022-01-12 Occlugel Hydrophilic degradable microspheres for delivering buprenorphine
US12465564B2 (en) 2021-10-25 2025-11-11 Aquestive Therapeutics, Inc. Oral and nasal compositions and methods of treatment

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5562012A (en) * 1978-11-06 1980-05-10 Teijin Ltd Slow-releasing preparation
JPS5770816A (en) * 1980-10-17 1982-05-01 Ono Pharmaceut Co Ltd Multilayered film preparation of prostagladin of prolonged action
US4582384A (en) 1984-05-04 1986-04-15 Amp Incorporated Overmolded shielded connector
JPS61280423A (ja) * 1985-06-05 1986-12-11 Kiyuukiyuu Yakuhin Kogyo Kk 口腔内粘膜貼付剤
US4713243A (en) * 1986-06-16 1987-12-15 Johnson & Johnson Products, Inc. Bioadhesive extruded film for intra-oral drug delivery and process
US5047244A (en) * 1988-06-03 1991-09-10 Watson Laboratories, Inc. Mucoadhesive carrier for delivery of therapeutical agent
US5236714A (en) * 1988-11-01 1993-08-17 Alza Corporation Abusable substance dosage form having reduced abuse potential
JP2656338B2 (ja) * 1989-01-31 1997-09-24 日東電工株式会社 口腔粘膜貼付製剤
JP3197035B2 (ja) * 1991-12-10 2001-08-13 積水化学工業株式会社 口腔粘膜適用製剤
US5346701A (en) * 1993-02-22 1994-09-13 Theratech, Inc. Transmucosal delivery of macromolecular drugs
DE69625549T2 (de) * 1995-06-27 2003-05-15 Kao Corp., Tokio/Tokyo Pflaster mit wasserlöslicher Klebeschicht
US5800832A (en) 1996-10-18 1998-09-01 Virotex Corporation Bioerodable film for delivery of pharmaceutical compounds to mucosal surfaces
DE19646392A1 (de) * 1996-11-11 1998-05-14 Lohmann Therapie Syst Lts Zubereitung zur Anwendung in der Mundhöhle mit einer an der Schleimhaut haftklebenden, Pharmazeutika oder Kosmetika zur dosierten Abgabe enthaltenden Schicht
DE19652188C2 (de) * 1996-12-16 2002-02-14 Lohmann Therapie Syst Lts Flache Arzneizubereitung zur Applikation und Freisetzung von Buprenorphin oder einer pharmakologisch vergleichbaren Substanz in der Mundhöhle und Verfahren zu ihrer Herstellung
US5968547A (en) * 1997-02-24 1999-10-19 Euro-Celtique, S.A. Method of providing sustained analgesia with buprenorphine
ES2252865T3 (es) * 1997-09-26 2006-05-16 Noven Pharmaceuticals, Inc. Composiciones bioadhesivas y metodos para la administracion topica de agentes activos.
DK1685839T3 (da) * 1997-12-22 2013-06-24 Euro Celtique Sa Farmaceutisk oral doseringsform omfattende en kombination af en opioidagonist og opioidantagonist
CN1204890C (zh) * 1997-12-22 2005-06-08 欧罗赛铁克股份有限公司 防止阿片样物质滥用的方法
US6200604B1 (en) * 1998-03-27 2001-03-13 Cima Labs Inc. Sublingual buccal effervescent
US6227384B1 (en) 1999-04-30 2001-05-08 Haworth, Inc. Slotted divider arrangement
US6264981B1 (en) * 1999-10-27 2001-07-24 Anesta Corporation Oral transmucosal drug dosage using solid solution
DE19960154A1 (de) * 1999-12-14 2001-07-12 Lohmann Therapie Syst Lts Flache Arzneizubereitung zur transmucosalen Verabreichung von Oxycodon oder einem vergleichbaren Wirkstoff in der Mundhöhle, für die Anwendung in der Schmerztherapie und Suchttherapie
WO2001091553A1 (en) * 2000-05-26 2001-12-06 Demegen, Inc. Composite wafer for controlled drug delivery
JP4850346B2 (ja) * 2001-03-15 2012-01-11 救急薬品工業株式会社 粘膜貼付剤
US6585997B2 (en) * 2001-08-16 2003-07-01 Access Pharmaceuticals, Inc. Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds
US20030194420A1 (en) * 2002-04-11 2003-10-16 Richard Holl Process for loading a drug delivery device
DE10252726B4 (de) * 2002-11-13 2008-05-08 Lts Lohmann Therapie-Systeme Ag Mehrschichtiges transmucosales therapeutisches System
SE0302947D0 (sv) * 2003-01-24 2003-11-07 Magle Ab A composition material for transmucosal delivery
SE0300187D0 (sv) * 2003-01-24 2003-01-24 Magle Ab A smokeless tobacco substitute material
US8790689B2 (en) * 2003-04-30 2014-07-29 Purdue Pharma L.P. Tamper resistant transdermal dosage form
DE10328942A1 (de) * 2003-06-27 2005-01-27 Lts Lohmann Therapie-Systeme Ag Transmukosale Darreichungsformen mit verminderter Schleimhautirritation
US8173840B2 (en) * 2003-07-29 2012-05-08 Signature R&D Holdings, Llc Compounds with high therapeutic index
US20050042281A1 (en) * 2003-08-21 2005-02-24 Singh Nikhilesh N. Compositions for delivering therapeutic agents across the oral mucosa
AU2004284080B2 (en) * 2003-10-24 2008-10-02 Adhesives Research, Inc. Disintegratable films for diagnostic devices
EP1677771A2 (en) * 2003-10-30 2006-07-12 Alza Corporation Transdermal analgesic systems having reduced abuse potential
WO2005055945A2 (en) * 2003-12-08 2005-06-23 Gel-Del Technologies, Inc. Mucoadhesive drug delivery devices and methods of making and using thereof
JP4727499B2 (ja) * 2005-07-13 2011-07-20 日本電子株式会社 走査型プローブ顕微鏡及びその動作方法
WO2007070632A2 (en) * 2005-12-13 2007-06-21 Biodelivery Sciences International, Inc. Abuse resistant transmucosal drug delivery device
AU2007275581B2 (en) * 2006-07-21 2011-09-08 Biodelivery Sciences International, Inc. Transmucosal delivery devices with enhanced uptake
EP1897543A1 (en) * 2006-08-30 2008-03-12 Euro-Celtique S.A. Buprenorphine- wafer for drug substitution therapy
US8470361B2 (en) * 2006-12-04 2013-06-25 Orexo Ab Non-abusable pharmaceutical composition comprising opioids
GB2447015A (en) * 2007-03-01 2008-09-03 Reckitt Benckiser Healthcare Analgesic composition comprising a specific ratio of buprenorphine and naltrexone

Similar Documents

Publication Publication Date Title
JP2019156859A5 (enExample)
JP2009544619A5 (enExample)
RU2019118034A (ru) Способ трансмукозальной доставки лекарства, средство трансмукозальной доставки лекарства (варианты) и способ лечения боли
JP6353089B2 (ja) 積層製剤
RU2432950C2 (ru) Подъязычный спрей на основе фентанила
JP2009535397A (ja) 経粘膜的組成物
WO2004091512A3 (en) Abuse-resistant oral dosage forms and method of use thereof
JP2009536147A5 (enExample)
HUP0203733A2 (en) Flat medicinal preparation for transmucosal administration of oxycodon or a comparable active ingredient in the oral cavity, for use in pain therapy and in addiction therapy
CN102056578A (zh) 多向粘膜给药装置及使用方法
JP2010510260A5 (enExample)
WO2004002445A3 (en) Novel floating dosage form
KR101307650B1 (ko) 구역에 대한 경피 방법 및 패치
JP5134973B2 (ja) 医薬の組み合わせでの処置方法およびこれに適する医薬の組み合わせ
US20090291123A1 (en) Opioid Combination Wafer
JP2003176227A (ja) 製薬組成物、喫煙を控えている患者の喫煙禁断症状を軽減する方法及び患者の喫煙禁断症状を軽減するキット
US20010034320A1 (en) NK1-receptor antagonists for treating restless legs syndrome
RU2017143388A (ru) Композиции стимуляторов, предотвращающие злоупотребление ими
US11207330B2 (en) Mirtazapine for use in medication overuse headache based on tension-type headache
JP2007509031A (ja) ガランタミンの口腔用製剤およびその使用
CA2405238C (en) Single-dose antihistamine/decongestant formulations for treating rhinitis
GEAP202616852A (en) Solid oral dosage form comprising antibodies for sustained release in the lower gastrointestinal tract
KR20100052490A (ko) (2ｓ)-(4ｅ)-ｎ-메틸-5-(3-(5-이소프로폭시피리딘)일)-4-펜텐-2-아민의 경피투여
MX2014007350A (es) Dispositivos de administracion de farmacos por via transmucosal para uso en el alivio del dolor cronico.
TWI386191B (zh) 用於嘔吐之經皮給藥方法及貼片